ESC Congress coverages: The interventional cardiology perspective

Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Alessandro Sticchi interviews Pierre Deharo about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam.
When comparing long-term outcomes of transcatheter edge-to-edge repair (TEER) versus isolated mitral valve repair surgery, the analysis revealed that cardiovascular death was lower among...

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Alex Sticchi interviews Julien Dreyfus about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam, which suggests that, in patients with severe TR, a curative intervention should be considered at an early stage of the disease as assessed by...